Derivative valuation adjustment, usually shortened to XVA, is the family of adjustments that banks make to the theoretical value of a derivative to reflect costs and risks left out of standard pricing models. Classical models value a swap or option by discounting expected cash flows at a risk-free rate, assuming that both parties will pay in full and that funding, margin and capital are free. In practice none of these holds. Each XVA measures the value of one of these departures, and the X stands for the letter that identifies it.
The first adjustment in wide use was the credit valuation adjustment (CVA), applied by large dealers well before 2007. After the financial crisis of 2007 to 2009, higher funding spreads, mandatory margin and tighter capital rules made the other adjustments material, and banks set up XVA desks to calculate, price and manage them across their OTC derivatives books.
The main adjustments
- CVA. The expected loss from the counterparty's default while it owes the bank money.
- DVA. The debit valuation adjustment (DVA), the mirror of CVA, reflecting the bank's own default risk while it owes the counterparty.
- FVA. The funding valuation adjustment (FVA), the cost or benefit of funding uncollateralised exposure at the bank's own borrowing rate rather than the risk-free rate.
- ColVA. The collateral valuation adjustment, the value of features of a credit support annex (CSA), such as the right to choose which currency or asset to post, or a collateral interest rate that differs from the discounting rate.
- MVA. The margin valuation adjustment, the cost of funding the initial margin the bank must post over the life of the trade, to a central counterparty (CCP) or under the uncleared margin rules.
- KVA. The capital valuation adjustment, the cost of holding regulatory capital against the trade for its life, charged at the bank's required return on capital.
Combining the adjustments
Under one common sign convention, the adjusted value of a portfolio is:
Here is the risk-free value, and each adjustment is defined as a positive amount with the sign showing whether it lowers or raises value. ColVA is added or subtracted depending on the collateral terms, and some banks split FVA into a cost on assets and a benefit on liabilities. Each adjustment is computed from simulated future exposures, collateral balances, margin requirements or capital, discounted and multiplied by the relevant spread or rate.
For example, suppose an uncollateralised swap has a risk-free value of 2.00 million, with a CVA of 0.13 million, a DVA of 0.06 million, an FVA of 0.05 million, an MVA of 0.03 million and a KVA of 0.08 million. The adjusted value is million. The gap of 0.23 million is the amount an XVA desk would charge to the trading desk, and through it to the client, at inception.
The components overlap. DVA and the funding benefit in FVA both depend on the bank's own credit spread, so adding both can count the same benefit twice, and banks adopt conventions to avoid this. Adjustments are also computed for the whole netting set rather than for each trade, so the charge for a new trade is the incremental change it causes.
XVA desks and pricing
A central XVA desk takes over the counterparty, funding and capital risk of trades booked by other desks, in return for an internal charge set when each trade is done. The charge works in the same way as funds transfer pricing (FTP) for loans, so that traders see the full cost of a trade before agreeing a price. The desk hedges the market and credit sensitivities of its book and reports its profit and loss separately. Calculating XVA requires large-scale simulation of all trades and collateral agreements, which has made it one of the heaviest computing tasks in a bank.
Accounting and regulation
Under IFRS 13 and US GAAP, fair value must include counterparty and own credit risk, so CVA and DVA are part of reported derivative values. Many large dealers also began to include FVA in fair value in the early 2010s, on the view that market prices reflect funding costs. MVA and KVA are generally used in pricing and management reporting rather than in accounting values. On the regulatory side, Basel III sets a capital charge for CVA risk and excludes DVA from Common Equity Tier 1 capital, while margin rules for uncleared derivatives raised MVA. Banks' valuation controls, including independent price verification (IPV) and prudent valuation adjustments, cover XVA as part of fair value accounting.
Debate
FVA and KVA have been the most contested. In 2012 the academics John Hull and Alan White argued that funding costs should not enter the valuation of a derivative, because the value of an investment should not depend on how it is financed. Practitioners responded that funding costs are real and are passed on in prices, and the industry largely adopted FVA in pricing. Critics of KVA note that it turns regulatory capital, a constraint, into a valuation input whose size depends on the bank's own chosen hurdle rate. The adjustments also reward collateralisation and central clearing, which reduce most of them, and contribute to the large price differences between collateralised and uncollateralised trades.